47.19 USD
↘ 0.38 (0.80%)AT CLOSE (11:59 AM EDT)
Moderna, Inc. Common Stock
MRNANASDAQ • USD
47.12
↘ 0.07 (0.15%)
POST MARKET (AS OF 08:01 PM EDT)
Post Market
AS OF 08:01 PM EDT
47.12
↘ 0.07 (0.15%)
Market: CLOSED
Open?$47.27
High?$49.26
Low?$46.82
Prev. Close?$47.57
Volume?6.3M
Avg. Volume?7.2M
VWAP?$47.93
Rel. Volume?0.87x
Bid / Ask
Bid?$44.75 × 100
Ask?$47.20 × 100
Spread?$2.45
Midpoint?$45.98
Valuation & Ratios
Market Cap?18.7B
Shares Out?396.8M
Float?361.1M
Float %?91.0%
P/E Ratio?N/A
P/B Ratio?2.53
EPS?-$8.05
Dividend?0.00%
Ex-Dividend?N/A
Moderna, Inc. Common Stock (MRNA) is currently trading at $47.19. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. MRNA is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of May 29, 2026.
News
Profile
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Themes
Employees
4.7K
Market Cap
18.7B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2018-12-07
Address
325 BINNEY STREET
CAMBRIDGE, MA 02142
Phone: (617) 714-6500
CAMBRIDGE, MA 02142
Phone: (617) 714-6500
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?72
Momentum?35
Short Sent.?31
Piotroski F-Score?1/9Weak
Altman Z-Score?3.04Safe
Confidence?63%Moderate
Short InterestHigh
Short % of Float?16.08%High
Short Interest?58.1M
Days to Cover?5.6
Free Float361.1M
Avg Daily Volume10.3M
Settlement Date2026-05-15
Financial Health
Current Ratio?2.41Strong
Quick Ratio?2.35Strong
Cash Ratio?0.80Adequate
Debt/Equity?0.08Low
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?2.53CHEAP▾
Peers80
S&P64
P/S?8.42HIGH▾
Peers55
S&P11
P/FCF?N/A▾
EV/EBITDA?-5.5CHEAP▾
Peers100
S&P97
EV/Sales?7.83HIGH▾
Peers55
S&P17
Returns & Efficiency
ROE?-43.1%WEAK▾
Peers11
S&P3
ROA?-27.8%WEAK▾
Peers13
S&P3
Cash Flow & Enterprise
FCF?$-1603000000
Enterprise Value?$17.4B
Fundamentals ratios updated end of day